Advanced analytical and processing equipment powering cutting-edge pharmaceutical research, from drug formulation to quality control.
Shimadzu LC-20AD system with UV detector for precise chromatographic analysis of pharmaceutical compounds.
Separation and quantification of volatile compounds, residual solvents, and essential oil components.
Quantitative determination of drug concentrations through absorbance measurement across UV-Vis range.
Anton Paar system for characterisation of particle size distribution in formulations and nanomaterials.
Continuous processing for amorphous solid dispersions and enhanced bioavailability formulations.
Preservation of heat-sensitive biologicals and preparation of stable lyophilised dosage forms.
Rapid drying of liquid feeds into fine powders for microencapsulation and inhalation formulations.
Preparation of nano-emulsions, suspensions, and uniform dispersions at high shear rates.
Ultrasonic cavitation for nanoparticle preparation, cell lysis, and sample dispersion.
Rheological characterisation of semi-solid formulations, gels, and polymer solutions.
In-vitro drug release testing to ensure bioequivalence and quality compliance of dosage forms.
Automated biochemical assays for high-throughput analysis of biological and pharmaceutical samples.
Regulatory-compliant facility for preclinical pharmacological and toxicological studies.
In-vivo screening of drug candidates using zebrafish models for toxicity and efficacy studies.
Propagation and conservation of medicinal plants for phytochemical and pharmacognosy research.
Scale-up facility for manufacturing process refinement from lab bench to production readiness.
Networked workstations with internet access for computational research and molecular modelling.
Behavioural assessment tool for evaluating learning, memory, and conditioned avoidance responses.
Radiant heat method for measuring analgesic potency and pain threshold in preclinical studies.
Controlled electrical stimulation for anticonvulsant screening and epilepsy research models.
Isolated tissue preparations for studying drug effects on smooth muscle and organ responses.
Photoelectric locomotor activity monitor for screening CNS stimulant and depressant agents.
Motor coordination and muscle relaxant assessment through accelerating rotarod endurance testing.
Thermal nociception model with precise temperature control for central analgesic evaluation.
Spatial learning and memory assessment for evaluating nootropic and neuroprotective compounds.
The ADTL operates under approval from the Drugs Control Department, Government of Karnataka (License No. KTK/37/77/2023, dated July 5, 2023) — enabling SACP to conduct authorised testing of pharmaceutical substances under Schedules C & C1.
Services: Testing of pharmaceutical substances (Schedules C & C1), Active Pharmaceutical Ingredient (API) analysis, and comprehensive analytical method development & validation.
ACE is a Section 8 company established to foster innovation and entrepreneurship among pharmacy students and faculty. Associated with CORMIL (Centre for Optimisation Research in Medicine and Industrial Logistics) and CMPAT (Centre for Molecular Pharmacology and Translational Therapeutics) research centres.
A purpose-built clinical research facility coordinated through Adichunchanagiri Hospital, equipped for GCP-compliant trials with round-the-clock monitoring.
Continuous monitoring of clinical trial participants with dedicated nursing staff on site.
Independent ethics review boards ensuring regulatory compliance and participant safety.
Biometric-controlled access with deep freezer units for secure investigational product management.
Temperature-monitored and CCTV-surveilled document storage for trial records and source data.
Principal Investigators, Clinical Research Coordinators, nurses, and data management personnel.
Coordinated through Adichunchanagiri Hospital for seamless access to clinical departments and patients.
Explore state-of-the-art laboratories, government-approved testing facilities, and clinical trial capabilities at SACP.